Works matching DE "HUMAN Genome Sciences Inc."

Results: 52

A gene to drug venture: Poisson options analysis.

Published in:

R&D Management, 2001, v. 31, n. 2, doi. 10.1111/1467-9310.00210

By:

Brach, Marion A.;
Paxson, Dean A.

Publication type:

Article

Eli Lilly & Co v Human Genome Sciences Inc.

Published in:

Oxford Journal of Law & Religion, 2012, v. 1, n. 2, p. 529, doi. 10.1093/ojlr/rws008

By:

GILES, JESSICA

Publication type:

Article

Gene patent considered by English Court of Appeal.

Published in:

Journal of Commercial Biotechnology, 2010, v. 16, n. 3, p. 275, doi. 10.1057/jcb.2010.7

By:

Webber, Philip

Publication type:

Article

Funding the dream at the Mid-Atlantic Biotech Conference.

Published in:

2010

By:

King, Harley

Publication type:

Proceeding

US Financial accounts reports.

Published in:

Journal of Commercial Biotechnology, 2001, v. 7, n. 4, p. 361, doi. 10.5912/jcb404

By:

Crocker, Glenn

Publication type:

Article

After half-century's wait, approval paves path for new lupus drugs.

Published in:

Nature Medicine, 2011, v. 17, n. 4, p. 400, doi. 10.1038/nm0411-400a

By:

Ledford, Heidi

Publication type:

Article

News in brief.

Published in:: Nature Medicine, 2008, v. 14, n. 9, p. 900, doi. 10.1038/nm0908-900
Publication type:: Article

Human Genome Sciences ahead of schedule in Phase III Albuferon trial.

Published in:: Expert Review of Anti-infective Therapy, 2007, v. 5, n. 5, p. 765
Publication type:: Article

EU Case Reports.

Published in:

Journal of Generic Medicines, 2012, v. 9, n. 4, p. 228, doi. 10.1177/1741134312467451

By:

Burdon, Michael;
Mitchell, Ewen;
Lorenz, Juliane;
Stringer, Claire

Publication type:

Article

BAFF/BLyS inhibitors: A new prospect for treatment of systemic lupus erythematosus.

Published in:

IUBMB Life, 2012, v. 64, n. 7, p. 595, doi. 10.1002/iub.1046

By:

Fairfax, Kirsten;
Mackay, Ian R.;
Mackay, Fabienne

Publication type:

Article

Business digest.

Published in:: Chemistry & Industry, 2012, v. 76, n. 6, p. 19, doi. 10.1002/cind.7606_4.x
Publication type:: Article

SmithKline backs sequencing company.

Published in:

Nature, 1993, v. 363, n. 6428, p. 387, doi. 10.1038/363387b0

By:

Gershon, Diane

Publication type:

Article

News in brief.

Published in:: Nature Reviews Drug Discovery, 2012, v. 11, n. 8, p. 589, doi. 10.1038/nrd3821
Publication type:: Article

Deal watch: HGS and FivePrime in FGF 'ligand trap' deal.

Published in:: 2011
Publication type:: journal article

Landmark lupus approval opens door for next wave of drugs.

Published in:: 2011
Publication type:: journal article

Trial watch: BLYS-targeted antibody shows promise in Phase III SLE trial.

Published in:: 2009
Publication type:: journal article

Patent Watch.

Published in:

Nature Reviews Drug Discovery, 2008, v. 7, n. 9, p. 722, doi. 10.1038/nrd2679

By:

Harrison, Charlotte

Publication type:

Article

Benlysta makes history.

Published in:

Nature Biotechnology, 2011, v. 29, n. 4, p. 298, doi. 10.1038/nbt0411-298a

By:

Ratner, Mark

Publication type:

Article

People.

Published in:: Nature Biotechnology, 2011, v. 29, n. 4, p. 370, doi. 10.1038/nbt.1849
Publication type:: Article

People.

Published in:: Nature Biotechnology, 2011, v. 29, n. 1, p. 88, doi. 10.1038/nbt.1758
Publication type:: Article

Court voids HGS gene patent.

Published in:

Nature Biotechnology, 2010, v. 28, n. 4, p. 300, doi. 10.1038/nbt0410-300b

By:

Francisco, Michael

Publication type:

Article

Human Genome Sciences trial data wow lupus community.

Published in:

Nature Biotechnology, 2009, v. 27, n. 9, p. 779, doi. 10.1038/nbt0909-779

By:

Ratner, Mark

Publication type:

Article

Dyax backs albumin.

Published in:

Nature Biotechnology, 2008, v. 26, n. 7, p. 718, doi. 10.1038/nbt0708-718

By:

Ratner, Mark

Publication type:

Article

NEWS IN BRIEF.

Published in:

Nature Biotechnology, 2004, v. 22, n. 5, p. 497, doi. 10.1038/nbt0504-497

By:

C. S.;
P. M.;
K. K.;
M. B.;
A. S.;
K. H.;
P. B.;
P. J.

Publication type:

Article

HGS drug flop latest genomics setback.

Published in:

Nature Biotechnology, 2002, v. 20, n. 6, p. 533, doi. 10.1038/nbt0602-533a

By:

Reid, Brian

Publication type:

Article

HGS targets patent-expiring drugs.

Published in:

Nature Biotechnology, 2000, v. 18, n. 12, p. 1238, doi. 10.1038/82333

By:

Hollon, Tom

Publication type:

Article

Transatlantic biotech deal.

Published in:

Nature Biotechnology, 2000, v. 18, n. 4, p. 366, doi. 10.1038/74346

By:

Dorey, Emma

Publication type:

Article

People.

Published in:: Nature Biotechnology, 2000, v. 18, n. 4, p. 464, doi. 10.1038/74556
Publication type:: Article

Curtain falls on gene sequencing deal.

Published in:

Nature, 1998, v. 391, n. 6668, p. 621, doi. 10.1038/35452

By:

Butler, Declan

Publication type:

Article

MRC agrees terms of access to gene sequence databank.

Published in:

Nature, 1995, v. 375, n. 6526, p. 4, doi. 10.1038/375004c0

By:

Dickson, David

Publication type:

Article

HUGO and HGS clash over `utility' of gene sequences in US patent law.

Published in:

Nature, 1995, v. 374, n. 6525, p. 751, doi. 10.1038/374751a0

By:

Dickson, David

Publication type:

Article

Takeda gains access to HGS data-bank.

Published in:: Nature, 1995, v. 374, n. 6522, p. 484, doi. 10.1038/374484b0
Publication type:: Article

Merck releases first `gene index' sequences.

Published in:: Nature, 1995, v. 373, n. 6515, p. 549, doi. 10.1038/373549c0
Publication type:: Article

Terms of HGS deal boost search for new strategies.

Published in:

Nature, 1995, v. 373, n. 6513, p. 376

By:

D.B.

Publication type:

Article

HGS seeks exclusive option on all patents using its cDNA sequences.

Published in:

Nature, 1994, v. 371, n. 6497, p. 463, doi. 10.1038/371463a0

By:

Dickson, David

Publication type:

Article

Merck to back `public' sequencing.

Published in:

Nature, 1994, v. 371, n. 6496, p. 365, doi. 10.1038/371365b0

By:

D.D.

Publication type:

Article

Cancer geneticists sign deal with genome company.

Published in:

Nature, 1994, v. 368, n. 6467, p. 86

By:

C.M.

Publication type:

Article

Belimumab.

Published in:: Drugs in R&D, 2010, v. 10, n. 1, p. 55
Publication type:: Article

Belimumab: Anti-BLyS Human Monoclonal Antibody, Anti-BLyS Monoclonal Antibody, BmAb, Human Monoclonal Antibody to B-Lymphocyte Stimulator.

Published in:: Drugs in R&D, 2008, v. 9, n. 3, p. 197
Publication type:: Article

More Study Needed on Human Genome Anthrax Drug.

Published in:

Clinical Infectious Diseases, 2010, v. 50, n. 1, p. i

By:

D. K.

Publication type:

Article

Human Genome Starts Shipping New Anthrax Drug.

Published in:: Clinical Infectious Diseases, 2009, v. 48, n. 7, p. iii
Publication type:: Article

GSK wins over Human Genome Sciences.

Published in:: TCE: The Chemical Engineer, 2012, n. 854, p. 6
Publication type:: Article

Positive Phase III trial results of Benlysta™ for systemic lupus erythematosus.

Published in:: Expert Review of Clinical Immunology, 2009, v. 5, n. 5, p. 495
Publication type:: Article

Founder bows out as genomic firm slashes workforce.

Published in:

Nature, 2004, v. 428, n. 6982, p. 456, doi. 10.1038/428456a

By:

Wadman, Meredith

Publication type:

Article

Could AIDS treatments slip through patents loophole?

Published in:

Nature, 2000, v. 404, n. 6776, p. 322, doi. 10.1038/35006230

By:

Smaglik, Paul

Publication type:

Article

In brief.

Published in:: Nature, 2006, v. 441, n. 7097, p. 1047, doi. 10.1038/4411047a
Publication type:: Article

In brief.

Published in:: Nature, 2006, v. 440, n. 7083, p. 407, doi. 10.1038/440407a
Publication type:: Article

Market Watch.

Published in:: Nature, 2005, v. 438, n. 7069, p. 737, doi. 10.1038/438737b
Publication type:: Article

Seven days: 13-19 July 2012.

Published in:: Nature, 2012, v. 487, n. 7407, p. 276, doi. 10.1038/487276a
Publication type:: Article

Genome database goes (mostly) public.

Published in:

JNCI: Journal of the National Cancer Institute, 1994, v. 86, n. 22, p. 1664, doi. 10.1093/jnci/86.22.1664

By:

Jenks, Susan

Publication type:

Article